Development of Pyrazole Compounds as Antidiabetic Agent: A Review

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 5, 2014-06 ,pp. : 686-703

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1

By Parkes David G   Mace Kenneth F   Trautmann Michael E  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 2, 2013-02 ,pp. : 219-244

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

By Shibata T.   Matsui K.   Nagao K.   Shinkai H.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 211-219

Elsevier

Access to resources Recommend Favorite

New Trends in the Development of Oral Antidiabetic Drugs

By  

Current Medicinal Chemistry, Vol. 9, Iss. 1, 2002-01 ,pp. : 53-71

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of selective PPARγγ modulators as safe and effective antidiabetic agents

By Doshi Lalit S   Brahma Manoja Kumar   Bahirat Umakant A   Dixit Amol V   Nemmani Kumar VS  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 489-512

Informa Healthcare

Access to resources Recommend Favorite